Ceritinib / LDK378 / 1032900-25-6

• Post Date:

  Aug 18,2016

• Expiry Date:

  Aug 18,2017

• Detailed Description:

  Cas No. :1032900-25-6 Specs:98%min
  Payment Method: T/T
  Ceritinib (LDK378) is a drug for the treatment of lung cancer. It is an ALK inhibitor. It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) following treatment with crizotinib.

• CAS Registry Number:

  1032900-25-6

• Synonyms:

  ;LDK 378;5-chloro-n4-(2-((1-methylethyl)sulfonyl)phenyl)-n2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-2,4-pyrimidinediamine;LDK378;

• Molecular Formula:

  C₂₈H₃₆ClN₅O₃S

• Molecular Structure:

  

• Company:

  Shanghai Biopharmaleader Co.,Ltd     [ China ]        

• Contact:

  Brenda Xu

• Tel:

  021-50180596

• Fax:

  021-57758967

• Email:

  brenda@biopharmaleader.com